Pharmacology of the class 111 antiarrhythmic agent sematilide in patients with arrhythmias
- 15 January 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 69 (3), 206-212
- https://doi.org/10.1016/0002-9149(92)91306-o
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.Circulation, 1989
- Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: Evaluation in a conscious canine model of sudden deathJournal of the American College of Cardiology, 1987
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary deathAmerican Heart Journal, 1985
- Torsade de pointes induced by N-AcetylprocainamideJournal of the American College of Cardiology, 1984
- Sotalol, hypokalaemia, syncope, and torsade de pointes.Heart, 1984
- Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patientsJournal of the American College of Cardiology, 1983
- Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamideThe American Journal of Cardiology, 1980
- Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.Circulation, 1979
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970